Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Pfizer’s divested nutrition unit up 9% in Q1; Church & Dwight battles tough environment, toothbrush recall; Cyvex grows but fish meal trends sink Omega Protein; Reliv pins U.S. turnaround hopes on LunaRich launches.
You may also be interested in...
Nestle’s $11.85 billion acquisition of Pfizer’s pediatric nutritionals business came in above or at the upper end of most analysts’ expectations. With the deal, Nestle keeps the portfolio – projected to generate $2.4 billion in 2012 sales – away from rivals Danone and Mead Johnson.
Omega Protein acquired Cyvex Nutrition and InCon Processing in the past 15 months to enter the dietary supplement market and vertically integrate its omega-3 fish oil supply chain. The firm gained from a one-time settlement payment in 2011, but saw underlying earnings fall.
Bayer credits Aspirin, Aleve for consumer gains; Vitamin Shoppe thinking small with new stores; DSM nutrition grows on volume, Martek performance; more Sales & Earnings In Brief.